Rare diseases
Investigational molecules
Locations
Back to Germany12 clinical trials in Ebersberg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on triple-negative breast cancer treatment, evaluating the effectiveness of combining immunotherapy with conventional chemotherapy approaches.
Research aims to enhance treatment outcomes through targeted therapeutic combinations.
Studies examining treatment efficacy in patients with BRCA mutations, specifically targeting high-risk HER2-negative breast cancer cases.
Focused on improving survival rates through genetically-informed treatment strategies.
Investigation of advanced treatment protocols for HR+/HER2- early breast cancer, combining endocrine therapy with innovative therapeutic agents.
Evaluating enhanced treatment strategies for hormone-responsive breast cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
